Sandhill Capital Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-73,141
Closed -$13.5M 83
2020
Q2
$13.5M Sell
73,141
-34,676
-32% -$6.89M 1.58% 31
2020
Q1
$21.8M Sell
107,817
-808
-0.7% -$156K 2.92% 16
2019
Q4
$20.3M Buy
108,625
+1,790
+2% +$308K 2.26% 22
2019
Q3
$17.1M Buy
106,835
+6,000
+6% +$1.19M 2.08% 27
2019
Q2
$25.4M Buy
100,835
+6,279
+7% +$1.46M 3.22% 13
2019
Q1
$22.6M Buy
94,556
+3,474
+4% +$833K 3.16% 14
2018
Q4
$20.9M Buy
91,082
+32,195
+55% +$7.94M 3.45% 9
2018
Q3
$16.6M Buy
58,887
+1,361
+2% +$399K 2.47% 21
2018
Q2
$16.9M Buy
57,526
+1,746
+3% +$477K 2.67% 18
2018
Q1
$14.1M Buy
55,780
+4,123
+8% +$969K 2.31% 21
2017
Q4
$11.2M Buy
+51,657
New +$10.5M 1.98% 25

Other funds holding ICUI

Sandhill Capital Partners's ICUI Position: Q3 2020 in Review

Sandhill Capital Partners sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 73,141 shares — an estimated $13.5M sold.

Sandhill Capital Partners first reported a position in ICUI in Q4 2017 and held it in 11 quarters. The position peaked at $25.4M in Q2 2019. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

  • Sandhill Capital Partners reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
  • Sandhill Capital Partners sold 73,141 ICU Medical shares in Q3 2020, an estimated $13.5M.
  • Sandhill Capital Partners first reported a position in ICU Medical in Q4 2017 and held it in 11 quarters.
  • Sandhill Capital Partners's ICU Medical position peaked at $25.4M in Q2 2019.
  • 283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Sandhill Capital Partners's 13F filing for Q3 2020, filed 12 Nov 2020.